HomeInsightsStock Comparison

Ipca Laboratories Ltd vs Zenotech Laboratories Ltd Stock Comparison

Ipca Laboratories Ltd vs Zenotech Laboratories Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1367 as of 13 Jun 15:30.
  • The P/E Ratio of Ipca Laboratories Ltd changed from 28.9 on March 2020 to 57.4 on March 2024 . This represents a CAGR of 14.71% over 5 yearsThe P/E Ratio of Zenotech Laboratories Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Ipca Laboratories Ltd changed from ₹ 17538 crore on March 2020 to ₹ 31414 crore on March 2024 . This represents a CAGR of 12.36% over 5 yearsThe Market Cap of Zenotech Laboratories Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Ipca Laboratories Ltd for the Mar '25 is ₹ 2272 crore as compare to the Dec '24 revenue of ₹ 2265 crore. This represent the growth of 0.31% The revenue of Zenotech Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Ipca Laboratories Ltd for the Mar '25 is ₹ 249.63 crore as compare to the Dec '24 ebitda of ₹ 483.19 crore. This represent the decline of -48.34% The ebitda of Zenotech Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Ipca Laboratories Ltd changed from ₹ 166.21 crore to ₹ 65.78 crore over 8 quarters. This represents a CAGR of -37.09% The net profit of Zenotech Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Ipca Laboratories Ltd changed from 9.68 % on March 2020 to 19.13 % on March 2024 . This represents a CAGR of 14.60% over 5 yearsThe Dividend Payout of Zenotech Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ipca Laboratories Ltd

  • Ipca Laboratories Limited (IPCA) was incorporated on 19th October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
  • The products of the Company are now sold in over 100 countries across the globe.
  • The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.

About Zenotech Laboratories Ltd

  • Zenotech Laboratories Limited (Formerly Sunline Technologies Limited) was established in June, 1989 and changed to its present name effective on August 9, 2004.
  • The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products.
  • The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. During financial year 2004-05, the Hon'ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s.
  • Zenotech Technologies Limited with effect from November 1st , 2003.
  • The Company had issued 91,82,500 equity shares to erstwhile shareholders of M/s.

Ipca Laboratories Ltd News Hub

News

Ipca Laboratories Ltd soars 1.25%, Gains for third straight session

Ipca Laboratories Ltd is up for a third straight session in a row. The stock is quoting at...

Read more

12 Jun 2025 13:05

News

Board of Ipca Laboratories recommends final dividend

Ipca Laboratories announced that the Board of Directors of the Company at its meeting held...

Read more

29 May 2025 14:29

News

Ipca Laboratories to announce Quarterly Result

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2...

Read more

15 May 2025 15:38

News

Ipca Laboratories now holds 100% stake in Unichem Laboratories, Ireland

Ipca Laboratories announced that 100% of the paid-up equity share capital of Unichem Labor...

Read more

02 May 2025 11:27

News

Ipca Laboratories appoints President - Human Resources

Ipca Laboratories has appointed Saidutta Nanda as President - Human Resources of the compa...

Read more

03 Mar 2025 16:06

News

Ipca Laboratories Ltd down for fifth straight session

Ipca Laboratories Ltd is down for a fifth straight session today. The stock is quoting at ...

Read more

28 Feb 2025 13:35

Zenotech Laboratories Ltd News Hub

News

Zenotech Laboratories to conduct board meeting

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 25 A...

Read more

22 Apr 2025 10:13

News

Zenotech Laboratories schedules board meeting

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 28 J...

Read more

20 Jan 2025 10:14

News

Zenotech Laboratories to discuss results

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 23 O...

Read more

18 Oct 2024 10:44

News

Zenotech Laboratories schedules AGM

Zenotech Laboratories announced that the 35th Annual General Meeting (AGM) of the company ...

Read more

31 Aug 2024 15:35

News

Zenotech Laboratories schedules board meeting

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 26 J...

Read more

19 Jul 2024 10:39

News

Zenotech Laboratories to discuss results

Zenotech Laboratories will hold a meeting of the Board of Directors of the Company on 1 Ma...

Read more

25 Apr 2024 10:39

SWOT Analysis Of Ipca Laboratories Ltd

Strength

2

S

Weakness

4

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Zenotech Laboratories Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ipca Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Zenotech Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ipca Laboratories Ltd and Zenotech Laboratories Ltd

Which company has a larger market capitalization, Ipca Laboratories Ltd or Zenotech Laboratories Ltd?

Market cap of Ipca Laboratories Ltd is 34,685 Cr while Market cap of Zenotech Laboratories Ltd is 375 Cr

What are the key factors driving the stock performance of Ipca Laboratories Ltd and Zenotech Laboratories Ltd?

The stock performance of Ipca Laboratories Ltd and Zenotech Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ipca Laboratories Ltd and Zenotech Laboratories Ltd?

As of June 14, 2025, the Ipca Laboratories Ltd stock price is INR ₹1367.15. On the other hand, Zenotech Laboratories Ltd stock price is INR ₹61.49.

How do dividend payouts of Ipca Laboratories Ltd and Zenotech Laboratories Ltd compare?

To compare the dividend payouts of Ipca Laboratories Ltd and Zenotech Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions